National Lab Briefs

GAO Defends Livermore Investigation Three months after a congressman called for the General Accounting Office to retract its Inaccurate, misleading, and biased” investigation of Lawrence Livermore founder Edward Teller (see The Scientist, March 20,1989, page 1), the GAO has declined the offer. In a letter last month to Rep. Fortney (Pete) Stark (D-Calif.), who had led the quest for a retraction, the agency said that it stands by the conclusion of its June 1988 report that the letters Tel

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Three months after a congressman called for the General Accounting Office to retract its Inaccurate, misleading, and biased” investigation of Lawrence Livermore founder Edward Teller (see The Scientist, March 20,1989, page 1), the GAO has declined the offer. In a letter last month to Rep. Fortney (Pete) Stark (D-Calif.), who had led the quest for a retraction, the agency said that it stands by the conclusion of its June 1988 report that the letters Teller sent to the White House in 1983 and 1984 describing the glowing promise of the X-ray laser, a large Livermore project, were not unwarranted at the time. The three-page GAO memo informs Stark that ["while it could well be that some of (the Livermore scientists questioned in the investigation] have now changed theiropinions, we have... verified that we accurately reported what we were told at the time.”

The GAO letter is not likely to end ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies